Tercius, Alix J <br/><br/>
Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.  [electronic resource] 

 -  Pacing and clinical electrophysiology : PACE  Nov 2007 
 - 1331-5 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0147-8389 
<br/><br/><label>Standard No.: </label>10.1111/j.1540-8159.2007.00866.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Arrhythmia Agents--administration & dosage<br/>Atrial Fibrillation--diagnosis<br/>Atrial Flutter--diagnosis<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Electrocardiography--drug effects<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Magnesium Sulfate--administration & dosage<br/>Male<br/>Middle Aged<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome